Skip to main content

Advertisement

SpringerLink
Log in

Recommendations for the reporting of pleural mesothelioma

  • Recommendation
  • Published:
Virchows Archiv Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rusch VW (1995) A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108: 1122–1128

    PubMed  CAS  Google Scholar 

  2. Rusch VW, Venkatraman ES (1999) Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68:1799–1804

    Article  PubMed  CAS  Google Scholar 

  3. Sugarbaker DJ, Flores RM, Jaklitsch MT et al (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117:54–63

    Article  PubMed  CAS  Google Scholar 

  4. Sugarbaker DJ, Garcia JP, Richards WG et al (1996) Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 224:288–294

    Article  PubMed  CAS  Google Scholar 

  5. Churg A, Roggli VL, Galateau-Salle F et al (2004) Mesothelioma. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds) World health organization classification of tumours Pathology and genetics of tumours of the lung, pleura, thymus, and heart. IARC, Lyon pp 128–136

    Google Scholar 

  6. Chu AY, Litzky LA, Pasha TL et al (2005) Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Path 18:105–110

    Article  CAS  Google Scholar 

  7. Cury PM, Butcher DN, Fisher C et al (2000) Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Path 13:107–112

    Article  CAS  Google Scholar 

  8. Di Loreto C, Puglisi F, Di Lauro V et al (1998) TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Lett 124:73–78

    Article  PubMed  Google Scholar 

  9. Ordonez NG (1998) Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 22:1215–1221

    Article  PubMed  CAS  Google Scholar 

  10. Ordonez NG (1998) Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature. Am J Clin Pathol 109:85–89

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Vermont, Burlington, VT, USA

    Kelly J. Butnor, Thomas A. Sporn & Nelson G. Ordonez

  2. Duke University, Durham, NC, USA

    Kelly J. Butnor, Thomas A. Sporn & Nelson G. Ordonez

  3. M.D. Anderson Cancer Center, Houston, TX, USA

    Kelly J. Butnor, Thomas A. Sporn & Nelson G. Ordonez

  4. Department of Pathology, Fletcher Allen Health Care, 111 Colchester Ave., ACC Building, EP2-120, Burlington, VT, 05401, USA

    Kelly J. Butnor

Authors
  1. Kelly J. Butnor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas A. Sporn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nelson G. Ordonez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kelly J. Butnor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butnor, K.J., Sporn, T.A. & Ordonez, N.G. Recommendations for the reporting of pleural mesothelioma. Virchows Arch 450, 15–23 (2007). https://doi.org/10.1007/s00428-006-0301-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-006-0301-7

Keywords

Search

Navigation